MSB 3.19% 97.0¢ mesoblast limited

The FDA’s focus is thus far on tests and devices rather than the...

  1. 300 Posts.
    lightbulb Created with Sketch. 340
    The FDA’s focus is thus far on tests and devices rather than the condition.

    https://www.optometrytimes.com/view/fda-clears-the-first-early-detection-sepsis-test-in-emergency-department-focused-diagnostic-tools

    https://ambientclinical.com/2022/10/31/newly-released-fda-guidelines-sepsis-detection-means-hospitals/#:~:text=With%20this%20guidance%2C%20EHR%20companies,without%20obtaining%20FDA%20clearance%20first.
    Last edited by irenekwshiu: 20/03/24
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
97.0¢
Change
0.030(3.19%)
Mkt cap ! $1.107B
Open High Low Value Volume
94.0¢ 98.0¢ 92.0¢ $3.342M 3.477M

Buyers (Bids)

No. Vol. Price($)
4 33313 97.0¢
 

Sellers (Offers)

Price($) Vol. No.
97.5¢ 73982 2
View Market Depth
Last trade - 16.10pm 03/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.